Market Tracker

06/27 5:16pm ET

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

132.61
Delayed Data
As of 4:14pm ET
 -5.29 / -3.84%
Today’s Change
108.50
Today|||52-Week Range
194.73
-5.66%
Year-to-Date
Why Celator Pharmaceuticals Is Up 1,610% in 2016
8:23am / MotleyFool.com - Paid Partner Content
4 Cancer Drug Developers You Need to Have on Your Radar This Year
Jun 15 / MotleyFool.com - Paid Partner Content
Jazz Pharmaceuticals Offers HAL Study Data on JZP-110
Jun 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close137.90
Today’s open137.44
Day’s range131.24 - 137.50
Volume918,966
Average volume (3 months)789,631
Market cap$8.3B
Dividend yield--
Data as of 4:14pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)+462.37%
Earnings growth (this year)+17.29%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+12.95%
P/E ratio25.1
Price/Sales6.69
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.55+1.16%
IDXXIDEXX Laboratories I...-1.14-1.30%
MDVNMedivation Inc-0.34-0.60%
VRXValeant Pharmaceutic...-1.54-7.60%
Data as of 4:02pm ET, 06/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.79
Annual revenue (last year)$1.3B
Annual profit (last year)$329.5M
Net profit margin24.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts